Intestinal Tuberculosis Diagnostics and the Differentiation From Crohn's Disease
NCT01503099 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 550
Last updated 2012-01-02
Summary
One aims to devise a method for the screening and differentiation of intestinal tuberculosis and Crohn's Disease. Additionally, one aims to detect and survey multidrug resistant TB.
Conditions
- Intestinal Tuberculosis
- Pulmonary Tuberculosis
- Crohn's Disease
Sponsors & Collaborators
-
Helse Sor-Ost
collaborator OTHER_GOV -
The Unger-Vetlesen Medical Fund, Jersey, C.I
collaborator UNKNOWN -
Odd Fellow Medical Fund, Norway
collaborator UNKNOWN -
Lovisenberg Diakonale Hospital
lead OTHER
Principal Investigators
-
Bjorn Moum, M.D Ph.D · Oslo University Hospital, Aker
-
Gunnar Bjune, M.D Ph.D · University of Oslo, Dept. of International Health
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-10-31
- Primary Completion
- 2011-12-31
- Completion
- 2012-12-31
Countries
- India
- Norway
Study Locations
More Related Trials
-
Development of Novel Fecal Microbial Biomarkers for Inflammatory Bowel Disease
NCT05598489 ·Status: UNKNOWN
-
Postoperative REcurrence and DynamICs of T Cell Subsets in Crohn's Disease
NCT02770495 ·Status: COMPLETED ·Phase: PHASE3
-
Feasibility of a Minimally Invasive Diagnostic Algorithm in Suspected Crohn's Disease
NCT06882993 ·Status: RECRUITING ·Phase: NA
-
Immunological Consequences of CARD15/NOD2 Mutations in Crohn's Disease
NCT00780949 ·Status: COMPLETED ·Phase: NA
-
Risk Stratification of Rapid Disease Progression in Children With Crohn's Disease
NCT00790543 ·Status: COMPLETED
-
Immune Ablation and Stem Cell Support for Crohn's Disease
NCT00179842 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Comparative Study of MRI, US and CE for Assessing Treatment Response in Known Crohn's Disease
NCT03435016 ·Status: COMPLETED ·Phase: NA
-
Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets
NCT03090139 ·Status: COMPLETED
-
A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative Colitis
NCT04877990 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative Colitis
NCT03169894 ·Status: TERMINATED ·Phase: PHASE1
-
Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.
NCT06252493 ·Status: RECRUITING
-
Observational Study of Disease Severity in Participants Diagnosed With Crohn's Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn's Disease (Protocol P06484)
NCT01218360 ·Status: COMPLETED
-
Mother-to-Infant Transfer of Bacteriome, Fungome, Virome, and Metabolome in Health and Crohn's Disease
NCT05112497 ·Status: ACTIVE_NOT_RECRUITING
-
A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]
NCT00160524 ·Status: COMPLETED ·Phase: PHASE3
-
IUS Predicts Upadacitinib Efficacy in Patients With Moderate to Severe Crohn's Disease:a Prospective Study
NCT06573944 ·Status: RECRUITING
-
CD Patients Immune Status Evaluation
NCT04135482 ·Status: COMPLETED
-
A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)
NCT01369329 ·Status: COMPLETED ·Phase: PHASE3
-
Treg Immunotherapy in Crohn's Disease
NCT03185000 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Characterize Multidimensional Model to Predict the Course of Crohn's Disease (CD)
NCT03668249 ·Status: COMPLETED
-
An Observational Study to Assess Change in Disease Activity and Adverse Events in Adolescent and Adult Participants With Moderate to Severe Active Crohn's Disease (CD) in Japan
NCT06023030 ·Status: RECRUITING
-
Combined [18F]-FDG PET-MRI in Diagnostics and Surveillance of Small Bowel Crohn's Disease
NCT06796959 ·Status: COMPLETED
-
Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated With Ustekinumab
NCT03107793 ·Status: COMPLETED ·Phase: PHASE3
-
The CROCO Study: CROhn's Disease COhort Study
NCT05420233 ·Status: RECRUITING ·Phase: NA
-
B0151005 Open-Label Extension Study
NCT01345318 ·Status: COMPLETED ·Phase: PHASE2
-
An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease
NCT01009281 ·Status: TERMINATED ·Phase: PHASE2